Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | Sb |
| Molecular Weight | 121.76 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 3 |
SHOW SMILES / InChI
SMILES
[Sb+3]
InChI
InChIKey=FAWGZAFXDJGWBB-UHFFFAOYSA-N
InChI=1S/Sb/q+3
DescriptionSources: https://www.whocc.no/atcvet/atcvet_index/?code=QR05CA07https://www.ncbi.nlm.nih.gov/pubmed/5295139 | https://www.ncbi.nlm.nih.gov/pubmed/14851220 | https://www.ncbi.nlm.nih.gov/pubmed/8898332Curator's Comment: description was created based on several sources, including https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7ef48d40-6d63-440b-a73c-46d89f425936
Sources: https://www.whocc.no/atcvet/atcvet_index/?code=QR05CA07https://www.ncbi.nlm.nih.gov/pubmed/5295139 | https://www.ncbi.nlm.nih.gov/pubmed/14851220 | https://www.ncbi.nlm.nih.gov/pubmed/8898332
Curator's Comment: description was created based on several sources, including https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7ef48d40-6d63-440b-a73c-46d89f425936
Stibophen (Fuadin), an organic trivalent antimony compound, has been used for many years in the treatment of schistosomiasis. Stibophen is used as treatment of schistosomiasis by intramuscular injection. Stibophen is known to act by selectively inhibiting worm PFK.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Substantiation of maximum permissible levels of antimony trioxide and pentasulide in the atmospheric air of inhabitated places]. | 1989 Apr |
|
| Antimony impairs nucleotide excision repair: XPA and XPE as potential molecular targets. | 2010 Jul 19 |
|
| Investigation on the pharmacological profile of 2,6-diacetylpyridine bis(benzoylhydrazone) derivatives and their antimony(III) and bismuth(III) complexes. | 2012 Jul |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
069647RPT5
Created by
admin on Fri Dec 15 16:48:43 UTC 2023 , Edited by admin on Fri Dec 15 16:48:43 UTC 2023
|
PRIMARY | |||
|
23713-48-6
Created by
admin on Fri Dec 15 16:48:43 UTC 2023 , Edited by admin on Fri Dec 15 16:48:43 UTC 2023
|
PRIMARY | |||
|
1546167
Created by
admin on Fri Dec 15 16:48:43 UTC 2023 , Edited by admin on Fri Dec 15 16:48:43 UTC 2023
|
PRIMARY | RxNorm | ||
|
49867
Created by
admin on Fri Dec 15 16:48:43 UTC 2023 , Edited by admin on Fri Dec 15 16:48:43 UTC 2023
|
PRIMARY | |||
|
DTXSID10178380
Created by
admin on Fri Dec 15 16:48:43 UTC 2023 , Edited by admin on Fri Dec 15 16:48:43 UTC 2023
|
PRIMARY | |||
|
069647RPT5
Created by
admin on Fri Dec 15 16:48:43 UTC 2023 , Edited by admin on Fri Dec 15 16:48:43 UTC 2023
|
PRIMARY | |||
|
104894
Created by
admin on Fri Dec 15 16:48:43 UTC 2023 , Edited by admin on Fri Dec 15 16:48:43 UTC 2023
|
PRIMARY |
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD
